February 11, 2021 – Article
Coupon-Program Pivot: Meeting New Legal, Operational Hurdles Pharmaceutical Executive
January 15, 2021 – Client Alerts
Finalized HHS Drug Formulary Rebate Rule Faces Uncertain Future Under Biden Administration and Current Legal Challenge Health Care and Life Sciences Client Alert
December 22, 2020 – In the News
Jack Linehan Featured in “Health Plans, PBMs Must Disclose Their Accumulators, Maximizer Programs for New Transparency Rules” Podcast Managed Healthcare Executive
December 12, 2020 – In the News
Jack Linehan Featured in “Accumulator, Maximizer Regulation Picks Up at the State Level” Managed Healthcare Executive
December 9, 2020 – In the News
Jack Linehan Featured in “New Transparency Rules Mean Health Plans, PBMs Must Disclose Their Accumulators, Maximizer Programs” Managed Healthcare Executive
December 9, 2020 – Article
New State Copay Accumulator Laws Complicate the Coupon Compliance Landscape Managed Healthcare Executive
August 21, 2020 – Client Alerts
President Trump Signs Executive Orders on Drug Pricing and Domestic Supply Chain Reform Health Care and Life Sciences Client Alert
July 29, 2020 – Article
States Are Questioning Medicaid MCO Rx Benefits Chain Drug Review
July 9, 2020 – In the News
Jack Linehan Discusses Drug Pricing, Coupons, and Accumulators in Managed Healthcare Executive Podcast Managed Healthcare Executive
June 17, 2020 – Article
The Government Goes Back to the Future in Its Evolving Regulation of Drug Coupon Accumulator Programs Managed Healthcare Executive
January 20, 2020 – Article
DSCSA Delays Raise Doubts Chain Drug Review
August 16, 2019 – Article
August 21 Effective Date for New EPA Standards for Management of Hazardous Waste Pharmaceuticals Health Law Advisor Blog
July 21, 2019 – In the News
Jack Linehan Featured in Interview on Copay Accumulators, Copay Coupons, and Copay Maximizers Managed Care
July 19, 2019 – Client Alerts
State Implementation of New EPA Standards for Maintenance of Hazardous Waste Pharmaceuticals: Drug Supply Chain Implications Health Care and Life Sciences Client Alert
May 8, 2019 – In the News
Six Epstein Becker Green Attorneys Featured in “Law360 Names Attys Who Moved Up the Firm Ranks in Q1″ Law360
April 16, 2019 – Article
State Legislatures Spring Ahead with Restrictions on Drug Copay Accumulators Managed Care
February 15, 2019 – In the News
John Linehan Quoted in “Trump’s Drug Rebate Ban Faces Fraught Legal Path” Law360
February 5, 2019 – Client Alerts
HHS OIG Proposes Anti-Kickback Safe Harbor Amendments to Regulate and Restrict the Provision of Manufacturer Remuneration to Plan Sponsors and PBMs Health Care and Life Sciences Client Alert
December 5, 2018 – Client Alerts
CMS Releases Medicare Advantage and Part D Drug Pricing Proposed Rule for Contract Year 2020 Health Care and Life Sciences Client Alert
October 25, 2018 – Article
CMS Seeks to Revamp Medicare Part B Drug Reimbursement through Proposed International Pricing Index (IPI) Model Health Law Advisor Blog
October 19, 2018 – Article
New Federal Laws Banning “Gag Clauses” in the Pharmacy Health Law Advisor Blog
January 3, 2018 – Client Alerts
Comment Deadline Approaches for CMS’s Proposed Changes to Medicare Advantage and Part D Programs for CY 2019 – Part 1: Negotiated Prices for Drugs Health Care and Life Sciences Client Alert
January 3, 2018 – Client Alerts
Comment Deadline Approaches for CMS’s Proposed Changes to Medicare Advantage and Part D Programs for CY 2019 – Part 2: Beneficiary Cost, Access, and Protection Health Care and Life Sciences Client Alert
May 2017 – Videos & Podcasts
Trends in Drug Pricing and Reimbursement: Thought Leaders in Health Law Video Series
April 7, 2017 – In the News
John Linehan Quoted in “PBM Executive Pleads Guilty in $3.5 Million Kickback Scheme” Drug Benefit News
March 24, 2017 – In the News
Epstein Becker Green’s Successful Defense of False Claims Act Case Noted in Multiple Publications Multiple Publications
January 17, 2017 – In the News
John Linehan Quoted in “Path of Uncertainty: Pharm Exec’s 2017 Industry Forecast” PharmExec.com
December 14, 2016 – Article
The Future Impact of Populism on Drug Pricing Reform Health Law Advisor
December 8, 2016 – Article
Conflicting State Compounding Regulations Create Barriers for FDA-Registered Outsourcing Facilities Specialty Pharmacy Times
December 8, 2016 – Article
Politics, Populism, and the Future of Prescription Drug Pricing Reform PharmExec.com
- Page 1 of 2